Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.67 |
| ▸ | PLAU | P00749 | 1/20 | 0.67 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 3/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | LMNA | P02545 | 2/20 | 0.65 |
| ▸ | RAB9A | P51151 | 2/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.65 |
| ▸ | MAPT | P10636 | 2/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.65 |
| ▸ | NPC1 | O15118 | 1/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.65 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.65 |
| ▸ | HTT | P42858 | 1/20 | 0.65 |
| ▸ | GMNN | O75496 | 1/20 | 0.65 |
| ▸ | PKM | P14618 | 1/20 | 0.65 |
| ▸ | THPO | P40225 | 1/20 | 0.65 |
| ▸ | MTOR | P42345 | 1/20 | 0.65 |
| ▸ | RECQL | P46063 | 1/20 | 0.65 |
| ▸ | BLM | P54132 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL985038 | 1.00 | F2 (0.67) | F2PLAUST14POLBALDH1A1 | |
| SCHEMBL3006160 | 1.00 | F2 (0.67) | F2PLAUST14POLBALDH1A1 | |
| Dibrompropamidine SCHEMBL30231952 | 0.96 | F2 (0.72) | F2PLAUST14POLBALDH1A1 | |
| Dibrompropamidine SCHEMBL871570 | 0.96 | F2 (0.72) | F2PLAUST14POLBALDH1A1 | |
| Dibrompropamidine SCHEMBL2471251 | 0.96 | F2 (0.72) | F2PLAUST14POLBALDH1A1 | |
| SCHEMBL14599538 | 0.85 | F2 (0.90) | F2PLAUST14PRSS1KLK1 | |
| SCHEMBL597315 | 0.85 | F2 (0.90) | F2PLAUST14PRSS1KLK1 | |
| Dibrompropamidine SCHEMBL29709297 | 0.81 | F2 (1.00) | F2PLAUST14PRSS1 | |
| Dibrompropamidine SCHEMBL292947 | 0.81 | F2 (1.00) | F2PLAUST14PRSS1 | |
| Dibrompropamidine SCHEMBL29232796 | 0.81 | F2 (0.71) | F2PLAUST14PRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4709829-A1 | FILMS AND THEIR USE IN HOME CARE COMPOSITIONS | Colgate-Palmolive Company (US) | 2026-03-18 | — | — | EP | disclosed |
| US-12545860-B2 | Mannanase variants | BASF SE (DE) | 2026-02-10 | — | — | US | disclosed |
| WO-2025007084-A1 | FILMS AND THEIR USE IN HOME CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2025-01-02 | — | — | WO | disclosed |
| EP-4453838-A1 | ENVIRONMENTAL ATTRIBUTES FOR CARE COMPOSITION INGREDIENTS | BASF SE (DE) | 2024-10-30 | — | — | EP | disclosed |
| CN-118435218-A | Environmental attributes of the care composition ingredients | 巴斯夫欧洲公司 | 2024-08-02 | — | — | CN | disclosed |
| US-20240132808-A1 | Storage-Stable Hydrolase Containing Liquids | BASF SE (DE) | 2024-04-25 | — | — | US | disclosed |
| CN-117084953-A | Hair care or hair cleaning composition or skin care or skin cleaning composition | 魏德曼控股股份公司 | 2023-11-21 | — | — | CN | disclosed |
| EP-4265237-A1 | HAIR CARE OR HAIR CLEANSING OR SKIN CARE OR SKIN CLEANSING COMPOSITION | Weidmann Holding AG (CH) | 2023-10-25 | — | — | EP | disclosed |
| CN-116919865-A | Dry mixture | 魏德曼控股股份公司 | 2023-10-24 | — | — | CN | disclosed |
| EP-3606500-B1 | PERSONAL CARE COMPOSITION | WEIDMANN HOLDING AG (CH) | 2023-10-04 | — | — | EP | disclosed |
| WO-2021105336-A1 | COMPOSITIONS COMPRISING POLYMER AND ENZYME | BASF SE (DE) | 2021-06-03 | — | — | WO | disclosed |
| WO-2021094127-A1 | A FABRIC CARE COMPOSITION COMPRISING HYDROPHOBICALLY MODIFIED POLYALKYLENEIMINE AND A BIOCIDE | BASF SE (DE) | 2021-05-20 | — | — | WO | disclosed |
| WO-2021074430-A1 | STORAGE-STABLE HYDROLASE CONTAINING LIQUIDS | BASF SE (DE) | 2021-04-22 | — | — | WO | disclosed |
| US-20210007941-A1 | PERSONAL CARE COMPOSITION | WEIDMANN HOLDING AG (CH) | 2021-01-14 | — | — | US | disclosed |
| EP-3687497-A1 | TOPICAL COMPOSITION AND METHOD FOR TREATING AND PREVENTING ATOPIC DERMATITIS AND INFECTIONS RELATED TO BACTERIA BIOFILM | Johnson & Johnson Consumer Inc. (US) | 2020-08-05 | — | — | EP | disclosed |
| CN-111372565-A | Topical compositions and methods for treating and preventing bacterial biofilm-associated atopic dermatitis and infections | 强生消费者公司 | 2020-07-03 | — | — | CN | disclosed |
| EP-3606500-A1 | PERSONAL CARE COMPOSITION | Weidmann Holding AG (CH) | 2020-02-12 | — | — | EP | disclosed |
| WO-2019064162-A1 | TOPICAL COMPOSITION AND METHOD FOR TREATING AND PREVENTING ATOPIC DERMATITIS AND INFECTIONS RELATED TO BACTERIA BIOFILM | JOHNSON & JOHNSON CONSUMER INC. (US) | 2019-04-04 | — | — | WO | disclosed |
| US-20190091148-A1 | TOPICAL COMPOSITION AND METHOD FOR TREATING AND PREVENTING ATOPIC DERMATITIS AND INFECTIONS RELATED TO BACTERIA BIOFILM | KENVUE BRANDS LLC | 2019-03-28 | — | — | US | disclosed |
| WO-2018185230-A1 | PERSONAL CARE COMPOSITION | WEIDMANN HOLDING AG (CH) | 2018-10-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12545860-B2 | Mannanase variants | MAN2A1, MANBA, IDUA | F2 3163/4885PLAU 3821/4885ST14 1470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.